Suchergebnisse - (Subject:"Lopinavir")

PubPharm (3.163)

101

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

enthalten in: Journal of pharmaceutical sciences | 2022

von Sahin, G. | Akbal-Dagistan, O. | Culha, M. | +4

102

Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients : An updated network meta-analysis of 48 randomized controlled trials

enthalten in: Medicine | 2022

von Cheng, Q. | Zhao, G. | Chen, J. | +2

103

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques

enthalten in: International journal of molecular sciences | 2022

von Okafor, S. | Angsantikul, P. | Ahmed, H.

104

A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study

enthalten in: Molecular diversity | 2022

von Novak, J. | Potemkin, V.

105

COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy

enthalten in: The Journal of infection | 2022

von Coulson, J. | Adams, A. | Gray, L. | +1

CommentIn: J Infect. 2022 Nov;85(5):e134-e136. - PMID 35995309

106

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE) : A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

enthalten in: PLoS medicine | 2022

von Lowe, D. | Brown, L. | Chowdhury, K. | +15

107

A systematic review and Bayesian network meta-analysis for comparative safety assessment of favipiravir interventions in hospitalized COVID-19 patients

enthalten in: Journal of infection in developing countries | 2022

von Yang, K. | Zeng, J. | Dai, W. | +2

108

Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy

enthalten in: European journal of hospital pharmacy : science and practice | 2022

von Desideri, I. | Martinelli, C. | Ciuti, S. | +2

109

In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease

enthalten in: Molecules (Basel, Switzerland) | 2022

von Kashyap, P. | Thakur, M. | Singh, N. | +7

110

Can transcription factors in the intervertebral disc of lopinavir/ritonavir prevent degeneration in the nucleus pulposus by mediating the regulation of inflammation through signaling pathways?

enthalten in: European review for medical and pharmacological sciences | 2022

von Yilmaz, I. | Akalan, H. | Karaarslan, N. | +5